EA201190326A1
(ru )
2012-06-29
Полипептиды гормона роста и способы их получения и применения
MX2011008094A
(es )
2012-02-13
Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
EP2470559A4
(en )
2013-07-31
COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING THEM
WO2013040093A3
(en )
2014-05-08
Glucagon-like peptide-2 compositions and methods of making and using same
WO2011084808A3
(en )
2011-10-13
Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
UA97516C2
(ru )
2012-02-27
Полностью человеческое моноклональное антитело против vap-1
MY188897A
(en )
2022-01-12
Factor viii compositions and methods of making and using same
WO2011123813A3
(en )
2011-12-01
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
WO2012045082A3
(en )
2012-06-07
Engineered nucleic acids and methods of use thereof
WO2011028344A3
(en )
2011-06-16
Interleukin-1 receptor antagonist compositions and methods of making and using same
BR112014018630A2
(pt )
2017-07-04
alvejamento de glicanos de sulfato de condroitina
MX2009002816A
(es )
2009-05-28
Proteinas de fusion de albumina.
IN2012DN02981A
(xx )
2015-07-31
MX2015012361A
(es )
2016-04-28
Metodos de fabricacion para controlar el contenido de lisina c-terminal, galactosa y acido sialico en proteinas recombinantes.
WO2007096192A3
(en )
2008-01-17
Production of biologically active proteins
ZA200800517B
(en )
2008-11-26
Transplastomic plants expressing lumen-targeted protein
WO2012135805A3
(en )
2013-03-14
Delivery and formulation of engineered nucleic acids
AR092456A1
(es )
2015-04-22
Proteinas de fusion para el tratamiento de un sindrome metabolico
EA201492202A1
(ru )
2015-03-31
Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк
TW201129379A
(en )
2011-09-01
Anti-Orai1 antigen binding proteins and uses thereof
BR112012017345A2
(pt )
2015-11-03
"composições e métodos de pgl para a produção aumentada de isopreno e outros produtos com 6-fosfogliconolactonase (pgl)"
ATE533782T1
(de )
2011-12-15
Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
WO2011113027A3
(en )
2012-03-01
Npp1 fusion proteins
WO2014097113A3
(en )
2014-11-20
Production of therapeutic proteins in genetically modified mammalian cells
PH12015500771A1
(en )
2015-06-08
Novel fc gamma receptor iib variants